Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines

References

• American Academy of Pediatrics. Red Book: 2012 Report of the Committee on Infectious Diseases. Pickering LK, ed. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
   Google Scholar
• WHO. Control of epidemic meningococcal disease, 2nd ed. WHO practical guidelines; 1998. Available at: http://www.who.int/csr/resources/publications/meningitis/WHO_EMC_BAC_98_3_EN/en
   Google Scholar
• Hausdorff WP, Hajjeh R, Al-Mazrou A, Shibl A, Soriano-Gabarro M, Middle East & North Africa Vaccine-Preventable Diseases Regional Advisory Group. The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs. Vaccine 2007; 25:1935 - 44; http://dx.doi.org/10.1016/j.vaccine.2006.11.018; PMID: 17241707
   PubMed Web of Science ®Google Scholar
• Agrawal S, Nadel S. Acute bacterial meningitis in infants and children: epidemiology and management. Paediatr Drugs 2011; 13:385 - 400; http://dx.doi.org/10.2165/11593340-000000000-00000; PMID: 21999651
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al, Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737 - 46; http://dx.doi.org/10.1056/NEJMoa022823; PMID: 12724479
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893 - 7; PMID: 16163262
   PubMedGoogle Scholar
• Domínguez A, Prats G. Vacuna anti-Haemophilus influenzae tipo b. In: Salleras L, ed. Vacunaciones Preventivas, Principios y aplicaciones. 2ª Ed. Barcelona: Masson, 2003: 163-90.
   Google Scholar
• Ministerio de Sanidad, Servicios Sociales e Igualdad. Coberturas de vacunación, datos estadísticos. Available at: http://www.msc.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm#segundo (accessed 14 September 2012)
   Google Scholar
• Martínez AI, Domínguez A, Oviedo M, Minguell S, Jansà JM, Codina G, et al, Grupo de Trabajo sobre Enfermedad Meningocócica de Cataluña. [Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C]. Rev Esp Salud Publica 2009; 83:725 - 35; PMID: 20111820
   PubMed Web of Science ®Google Scholar
• Generalitat de Catalunya. Departament de Salut. Manual de vacunacions. Col·leció: Quaderns de salut pública, 14. 4th ed. Direcció General de Salut Pública. Barcelona 2006 Available at: http://www20.gencat.cat/docs/canalsalut/Home%20Canal%20Salut/Professionals/Temes_de_salut/Vacunacions/documents/manualvacunes06.pdf (accessed 14 September 2012).
   Google Scholar
• Blanco A, Gimenez F, Asensi F, Bernaola E, de Juan F, García J, et al, Comité Asesor de Vacunas de la Asociación Española de Pediatría. Vaccination schedule of the spanish association of pediatrics: recommendations 2004. An Pediatr (Barc) 2004; 60:468 - 72; PMID: 15105003
   PubMedGoogle Scholar
• Ciruela P, Soldevila N, Hernández S, Selva L. F. de Sevilla M, García-García JJ, et al. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes. Vaccine 2013; In Press
   Google Scholar
• Hausdorff WP. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 2002; 161:Suppl 2 S135 - 9; http://dx.doi.org/10.1007/s00431-002-1066-x; PMID: 12494260
   PubMed Web of Science ®Google Scholar
• Hanquet G, Perrocheau A, Kissling E, Bruhl DL, Tarragó D, Stuart J, et al, ECDC Country Experts for Pneumococcal Disease. Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?. Vaccine 2010; 28:3920 - 8; http://dx.doi.org/10.1016/j.vaccine.2010.03.069; PMID: 20394721
   PubMed Web of Science ®Google Scholar
• Roberts J, Chandra M, Pebody R, Stuart J. Variation in incidence of pneumococcal and meningococcal disease across Europe. Euro Surveill. 2007;12(46):pii=3310. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3310.
   Google Scholar
• WHO. Pneumococcal vaccines. Wordl Health Organization. Immunization, Vaccines and Biologicals. Available at: www.who.int/vaccines/in/pneumococcus.shtml.
   Google Scholar
• Pebody RG, Hellenbrand W, D’Ancona F, Ruutu P, European Union funded Pnc-EURO contributing group. Pneumococcal disease surveillance in Europe. Euro Surveill 2006; 11:171 - 8; PMID: 17075159
   PubMedGoogle Scholar
• Rodríguez MA, González AV, Gavín MA, Martínez FM, Marín NG, Blázquez BR, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine 2011; 29:5740 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.05.099; PMID: 21683112
   PubMed Web of Science ®Google Scholar
• Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, et al, Heracles Study Group. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin Vaccine Immunol 2011; 18:89 - 94; http://dx.doi.org/10.1128/CVI.00317-10; PMID: 21047996
   PubMed Web of Science ®Google Scholar
• Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010; 28:5167 - 73; http://dx.doi.org/10.1016/j.vaccine.2010.06.008; PMID: 20558247
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Mason EO Jr., Wald ER, Schutze GE, Bradley JS, Tan TQ, et al. Decrease of invasive infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal vaccine. Pediatrics 2004; 113:443 - 9; http://dx.doi.org/10.1542/peds.113.3.443; PMID: 14993532
   PubMed Web of Science ®Google Scholar
• Domínguez A, Ciruela P, García-García JJ, Moraga F, de Sevilla MF, Selva L, et al. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study. Vaccine 2011; 29:9020 - 5; http://dx.doi.org/10.1016/j.vaccine.2011.09.034; PMID: 21939724
   PubMed Web of Science ®Google Scholar
• Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46:174 - 82; http://dx.doi.org/10.1086/524660; PMID: 18171247
   PubMed Web of Science ®Google Scholar
• Moore MR. Rethinking replacement and resistance. J Infect Dis 2009; 199:771 - 3; http://dx.doi.org/10.1086/597045; PMID: 19434926
   PubMed Web of Science ®Google Scholar
• Makwana N, Riordan FAI. Bacterial meningitis: the impact of vaccination. CNS Drugs 2007; 21:355 - 66; http://dx.doi.org/10.2165/00023210-200721050-00001; PMID: 17447825
   PubMed Web of Science ®Google Scholar
• WHO. Meningococcal meningitis [online]. Available from URL: http://www.who.int/mediacentre/factsheets/fs141/in/index.html [Accessed 2011 Feb 18]
   Google Scholar
• Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 2009; 27:5513 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.06.091; PMID: 19615960
   PubMed Web of Science ®Google Scholar
• Jansen AG, Rodenburg GD, van der Ende A, van Alphen L, Veenhoven RH, Spanjaard L, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009; 49:e23 - 9; http://dx.doi.org/10.1086/600045; PMID: 19522653
   PubMed Web of Science ®Google Scholar
• Mothibeli KM, du Plessis M, von Gottberg A, de Gouveia L, Adrian P, Madhi SA, et al, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol 2010; 48:184 - 91; http://dx.doi.org/10.1128/JCM.01011-09; PMID: 19889905
   PubMed Web of Science ®Google Scholar
• Centers for Diseases Control and Prevention. Meningococcal disease: technical and clinical information [online]. Available from URL: http://www.cdc.gov/meningitis/clinica-info.html [Accessed 2001 Aug 17].
   Google Scholar
• Cartwright K, Noah N, Peltola H, Meningococcal Disease Advisory Board. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine 2001; 19:4347 - 56; http://dx.doi.org/10.1016/S0264-410X(01)00205-5; PMID: 11534497
   PubMedGoogle Scholar
• Connolly M, Noah N, European Meningitis Surveillance Group. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. Epidemiol Infect 1999; 122:41 - 9; http://dx.doi.org/10.1017/S0950268898001848; PMID: 10098784
   PubMed Web of Science ®Google Scholar
• Goldblatt D. Recent developments in bacterial conjugate vaccines. J Med Microbiol 1998; 47:563 - 7; http://dx.doi.org/10.1099/00222615-47-7-563; PMID: 9839559
   PubMed Web of Science ®Google Scholar
• Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001; 357:195 - 6; http://dx.doi.org/10.1016/S0140-6736(00)03594-7; PMID: 11213098
   PubMed Web of Science ®Google Scholar
• Trotter CL, Ramsay ME, Kaczmarski EB. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health 2002; 5:220 - 5; PMID: 12434692
   PubMedGoogle Scholar
• Domínguez A, Muñoz P, Cardeñosa N, Martínez A, Caylà JA, Meningococcal Disease Study Group. Time-series analyses of meningococcal disease in Catalonia. Ann Epidemiol 2007; 17:654 - 62; http://dx.doi.org/10.1016/j.annepidem.2007.03.006; PMID: 17555986
   PubMed Web of Science ®Google Scholar
• Cardeñosa N, Domínguez A, Martínez A, Alvarez J, Pañella H, Godoy P, et al, Working Group on Meningococcal Disease. Meningococcal disease in Catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine. Infection 2003; 31:392 - 7; PMID: 14735381
   PubMed Web of Science ®Google Scholar
• Salleras Ll, Domínguez A, Prats G, Parrón I, Muñoz P. Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people. J Epidemiol Community Health 2001; 55:283 - 7; http://dx.doi.org/10.1136/jech.55.4.283; PMID: 11238585
   PubMed Web of Science ®Google Scholar
• Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. Decret 318/2000 de 27 de setembre, pel qual es modifica l’annex del Decret 60/1999 de 9 de març, pel qual s’estableix calendari de vacunacions sistemàtiques. DOGC 3.242 de 10 d’octubre de 2000.
   Google Scholar
• Morant A, Díez J, Gimeno C, de la Muela N, Pereiró I, Brines J. [Epidemiology of Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae in children in the Valencia Community, Spain. Acute diseases study group]. Rev Neurol 1998; 26:34 - 7; PMID: 9533202
   PubMed Web of Science ®Google Scholar
• Centers for Diseases Control and Prevention. The impact of Haemophilus influenzae immunisation on invasive infection in children. Commun Dis Rep CDR Wkly 1993; 3:231; PMID: 7508794
   PubMedGoogle Scholar
• Booy R, Heath PT, Slack MP, Begg N, Moxon ER. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997; 349:1197 - 202; http://dx.doi.org/10.1016/S0140-6736(96)06392-1; PMID: 9130940
   PubMed Web of Science ®Google Scholar
• Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME, European Union Invasive Bacterial Infection Surveillance participants. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerg Infect Dis 2010; 16:455 - 63; http://dx.doi.org/10.3201/eid1603.090290; PMID: 20202421
   PubMed Web of Science ®Google Scholar
• Departament de Sanitat i Seguretat Social. Generalitat de Catalunya. Resum de les Malalties de Declaració Obligatòria durant l’any 1993. Butlletí Epidemiològic de Catalunya (BEC) 1994, núm 15 (extraordinari): 104-105.
   Google Scholar
• Departament de Sanitat i Seguretat Social. Generalitat de Catalunya. Resum de les Malalties de Declaració Individualitzada. Distribució quadrisetmanal. Butlletí Epidemiològic de Catalunya (BEC) 1995, núm 16 (extraordinari): 31-33.
   Google Scholar
• ECDC. (2009). Annual Epidemiological Report on Communicable Diseases in Europe 2009, pp.162. Stockholm: European Centre for Disease Prevention and Control.
   Google Scholar
• WHO. Haemophilus influenzae type b vaccine. World Health Organization. Immunization, Vaccines and Biologicals. Available at: http://www.who.int/immunization/topics/hib/en/index.html
   Google Scholar
• Campos J, Román F, Pérez-Vázquez M, Oteo J, Aracil B, Cercenado E, Spanish Study Group for Haemophilus influenzae Type E. Infections due to Haemophilus influenzae serotype E: microbiological, clinical, and epidemiological features. Clin Infect Dis 2003; 37:841 - 5; http://dx.doi.org/10.1086/377232; PMID: 12955648
   PubMed Web of Science ®Google Scholar
• Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A 1997; 94:6571 - 6; http://dx.doi.org/10.1073/pnas.94.12.6571; PMID: 9177259
   PubMed Web of Science ®Google Scholar
• Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010; 28:4073 - 8; http://dx.doi.org/10.1016/j.vaccine.2010.03.075; PMID: 20398617
   PubMed Web of Science ®Google Scholar
• McConnell A, Tan B, Scheifele D, Halperin S, Vaudry W, Law B, et al, of The Canadian Immunization Monitoring Program, ACTive (IMPACT). Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001. Pediatr Infect Dis J 2007; 26:1025 - 31; http://dx.doi.org/10.1097/INF.0b013e31812f4f5b; PMID: 17984810
   PubMed Web of Science ®Google Scholar
• Tsang RS, Mubareka S, Sill ML, Wylie J, Skinner S, Law DK. Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era. J Clin Microbiol 2006; 44:1530 - 5; http://dx.doi.org/10.1128/JCM.44.4.1530-1535.2006; PMID: 16597886
   PubMed Web of Science ®Google Scholar
• Singleton R, Hammitt L, Hennessy T, Bulkow L, DeByle C, Parkinson A, et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics 2006; 118:e421 - 9; http://dx.doi.org/10.1542/peds.2006-0287; PMID: 16882783
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006. MMWR Morb Mortal Wkly Rep 2007; 56:1077 - 80; PMID: 17947966
   PubMedGoogle Scholar
• Kinlin LM, Jamieson F, Brown EM, Brown S, Rawte P, Dolman S, et al. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. Vaccine 2009; 27:1735 - 40; http://dx.doi.org/10.1016/j.vaccine.2009.01.026; PMID: 19186206
   PubMed Web of Science ®Google Scholar
• Izquierdo C, Ciruela P, Hernandez S, Domínguez A. Vigilància epidemiològica de la infecció respiratòria aguda a Catalunya. Sistema de notificació microbiològica de Catalunya, 2005-2008. Butlleti Epidemiologic de Catalunya 2011;32 (4):38-42. Available at: http://www20.gencat.cat/docs/canalsalut/Home%20Canal%20Salut/Professionals/Recursos/Butlletins_de_salut/PROMOCIO_I_PROTECCIO_DE_LA_SALUT/BEC_Butlleti_epidemiologic_de_Catalunya/2011/Arxius/bec042011.pdf
   Google Scholar
• Fenoll A, Jado I, Vicioso D, Casal J. Dot blot assay for the serotyping of pneumococci. J Clin Microbiol 1997; 35:764 - 6; PMID: 9041430
   PubMed Web of Science ®Google Scholar
• Statistical institut of Catalonia. Available at: http://www.idescat.cat/cat/poblacio/poblestructura.html.
   Google Scholar